SCHEMBL10501312

SCHEMBL10501312

O=[N+]([O-])c1cccc(-n2[se]c3ccccc3c2=S)c1

nearest known ligand 0.74

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ SCN2A Q99250 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ HPN P05981 1/20 0.44
▸ METAP2 P50579 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.43
▸ MPI P34949 1/20 0.43
▸ APOBEC3G Q9HC16 1/20 0.43
▸ LMNA P02545 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ ABCG2 Q9UNQ0 1/20 0.41
▸ FGFR1 P11362 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10501872 0.85 METAP2 (0.62) MEN1KMT2ASCN2AKDM4EMAPT
SCHEMBL10503512 0.85 ALDH1A1 (0.44) MEN1KMT2ASCN2AKDM4EMAPT
SCHEMBL10502345 0.82 ALDH1A1 (0.50) MEN1KMT2AKDM4EMAPTMETAP2
SCHEMBL10501842 0.79 METAP2 (0.49) MEN1KMT2AKDM4EMAPTMETAP2
SCHEMBL10501265 0.78 MPI (0.49) MEN1KMT2AMAPTMETAP2ALDH1A1
SCHEMBL10502143 0.78 METAP2 (0.45) MEN1KMT2AMAPTMETAP2ALDH1A1
SCHEMBL10747422 0.76 MEN1 (0.41) MEN1KMT2AKDM4EMAPTMETAP2
SCHEMBL10501589 0.76 METAP2 (0.61) MEN1KMT2AKDM4EMAPTMETAP2
SCHEMBL10502481 0.76 METAP2 (0.46) MEN1KMT2AKDM4EMAPTMETAP2
SCHEMBL10501084 0.76 METAP2 (0.68) MEN1KMT2AKDM4EMAPTMETAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0154851-B1 BENZISOSELENAZOLETHIONES,PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PRODUCTS CONTAINING THESE COMPOUNDS A. Nattermann & Cie. GmbH (DE) 1989-08-02 — — EP disclosed
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback